Billionaire Steve Cohen’s Top 10 Small-Cap Stock Picks
In this article we presented billionaire Steve Cohen’s top 10 small-cap stock picks. You can skip our detailed discussion on Cohen’s investment...
Posts Tagged ‘NASDAQ:BCRX’
Billionaire Steve Cohen’s Top 5 Small-Cap Stock Picks
In this article we discuss the billionaire Steve Cohen’s top 5 small-cap stock picks. If you want to read our detailed analysis of Cohen’s...
Is BCRX Stock A Buy or Sell?
Many prominent investors, including Warren Buffett, David Tepper and Stan Druckenmiller, have been cautious regarding the current bull market and missed...
10 Best Small-Cap Biotech Stocks Under $10 in 2021
In this article we will list the 10 best small-cap biotech stocks under $10 in 2021. Click to skip ahead and see the 5 Best Small-Cap Biotech Stocks Under...
Is BCRX A Good Stock To Buy Now According To Hedge Funds?
In this article we will take a look at whether hedge funds think BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) is a good investment right now. We check...
Hedge Funds Keep Buying BioCryst Pharmaceuticals, Inc. (BCRX)
We know that hedge funds generate strong, risk-adjusted returns over the long run, which is why imitating the picks that they are collectively bullish...
Did Hedge Funds Make The Right Call On BioCryst Pharmaceuticals, Inc. (BCRX) ?
We know that hedge funds generate strong, risk-adjusted returns over the long run, which is why imitating the picks that they are collectively bullish...
Hedge Funds Have Never Been This Bullish On BioCryst Pharmaceuticals, Inc. (BCRX)
Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings...
Here is What Hedge Funds Think About BioCryst Pharmaceuticals, Inc. (BCRX)
Hedge funds are known to underperform the bull markets but that’s not because they are bad at investing. Truth be told, most hedge fund managers...
BioCryst Pharmaceuticals, Inc. (BCRX) Are Selling These Hedge Funds
“Since 2006, value stocks (IVE vs IVW) have underperformed 11 of the 13 calendar years and when they beat growth, it wasn’t by much. Cumulatively...
Is BioCryst Pharmaceuticals, Inc. (BCRX) A Good Stock To Buy?
With the first-quarter round of 13F filings behind us it is time to take a look at the stocks in which some of the best money managers in the world preferred...
Here’s What Hedge Funds Think About BioCryst Pharmaceuticals, Inc. (BCRX)
Is BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) a good investment right now? We check hedge fund and billionaire investor sentiment before delving into...
BioCryst Pharmaceuticals, Inc. (BCRX) Hedge Funds Are Snapping Up
It seems that the masses and most of the financial media hate hedge funds and what they do, but why is this hatred of hedge funds so prominent? At the...
13D Filing: RA Capital Management and Biocryst Pharmaceuticals Inc (BCRX)
Biocryst Pharmaceuticals Inc (NASDAQ:BCRX): Peter Kolchinsky’s RA Capital Management filed an amended 13D. You can check out RA Capital Management...
13G Filing: James E. Flynn and Biocryst Pharmaceuticals Inc (BCRX)
You can access the original SEC filing by clicking here. Ownership Summary Table Page 1 of 14 – SEC Filing SECURITIES AND EXCHANGE COMMISSION WASHINGTON...
33 Fresh Stories From The World Of Finance Today
1. U.S. Stock Market: “World stock markets scaled fresh highs on Thursday, with key U.S. indexes lifted by rosy retailer results, while the...
13G Filing: James E. Flynn and Biocryst Pharmaceuticals Inc (BCRX)
You can access the original SEC filing by clicking here. Ownership Summary Table Page 1 of 14 – SEC Filing SECURITIES AND EXCHANGE COMMISSION WASHINGTON...
32 Recent Stories to Keep You Informed About the Financial Markets Today
1. U.S. Stock Market: “U.S. stock-market benchmark traded firmly higher, with shares of Apple hitting a record, as investors digested a...
BioCryst Pharmaceuticals, Inc. (BCRX): A Discount Entry?
BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) has caught our attention in the biotech space as being a company that has had a bit of a strange start to...
What Smart Money Thinks about BioCryst Pharmaceuticals, Inc. (BCRX)?
Investing in hedge funds can bring large profits, but it’s not for everybody, since hedge funds are available only for high-net-worth individuals. They...
Biocryst Pharmaceuticals Inc (BCRX): Billionaire David E. Shaw’s Fund Increases Stake
Billionaire David E. Shaw‘s D E Shaw has recently filed a Form 13G with the US SEC in which it reported holding 3.74 million common shares of ...
Biocryst Pharmaceuticals Inc (BCRX): Baker Bros. Advisors Unloads Nearly 4 Million Shares
Julian Baker and Felix Baker‘s Baker Bros. Advisors recently filed an amended Form 13D with the SEC to report the sale of common shares of Biocryst...
Most Popular Healthcare Stocks Under $5
Most securities that cost less than a dinner at a fast-food restaurant are considered to be too risky, with most intra-day traders or other investors...
Biotech-Focused VHCP Management’s Bullish Moves and New Picks
Biotech stocks pop and drop on the smallest whims and whispers, which makes the biotechnology sector one of the most rewarding and volatile sectors out...
Venrock Healthcare Capital Partners Discloses 7.1% Stake in Biocryst Pharmaceuticals Inc (BCRX)
Anders Hove and Bong Koh‘s VHCP Management owns a new position in BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX), as a new filing with the US Securities...
D. E. Shaw & Co Raises Exposure to Biocryst Pharmaceuticals Inc (BCRX)
D. E. Shaw & Co, founded by billionaire David E. Shaw, has reported its position in BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) via a 13G filing...
Billionaire Ubben Cuts Stake in Adobe (ADBE), Carlson Buys More Archrock (AROC), and 2 Other Moves
There are numerous exceptional money managers who have been able to consistently beat broader market benchmarks, which is just one reason why tracking...
These 4 Stocks Were Just Bought by Baker Bros. Advisors, Clint Carlson, More
The hedge fund industry closed in negative territory for 2015, marking the fourth year of decline for the industry since 1990. Nonetheless, approximately...
Elite Hedge Funds Making Moves in These Three Stocks
Most investors monitor hedge funds’ 13F filings in order to identify high-potential stocks, and our research has provided evidence that these public...
Gap Inc, ANI Pharmaceuticals, Ruby Tuesday: Why Are These Stocks Getting Crushed Today?
It’s been a disappointing day for investors of Gap Inc (NYSE:GPS), BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX), Ruby Tuesday, Inc. (NYSE:RT...
RA Capital’s Latest Move In Alcobra Ltd (ADHD) Coming Off Hefty Second Quarter Gains
According to a recent filing with the Securities and Exchange Commission, Peter Kolchinsky‘s RA Capital has initiated a position in Alcobra Ltd (...
Array Biopharma Inc (ARRY), Vertex Pharmaceuticals Incorporated (VRTX): This Week in Biotech
With the SPDR S&P Biotech Index up 29% over the trailing-12-month period, it’s evident that investment dollars are willingly flowing into the...
Earnings Watch News: Alcoa Inc (AA), JPMorgan Chase & Co. (JPM), Wells Fargo & Co (WFC)
Don’t Put Too Much Stock In Alcoa For Earnings Season Insight (Forbes) Alcoa Inc (NYSE:AA) will provide the informal kickoff to first-quarter earnings...
Hedge Funds Are Selling BioCryst Pharmaceuticals, Inc. (BCRX)
BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) shareholders have witnessed a decrease in hedge fund interest lately. This is interesting, because the stock...
